**Question:** The most common cause of malignant adrenal mass is:

A. Primary adrenal cancer
B. Metastatic tumors from other organs (e.g., lung, breast, or kidney)
C. Adrenocortical carcinoma
D. Adrenal hemorrhage

**Core Concept:**
Adrenal masses can be broadly classified into benign and malignant lesions. Malignant adrenal masses primarily originate from the adrenal gland or spread to the adrenal gland from distant tumors. The primary adrenal cancer is adrenocortical carcinoma, while secondary tumors (metastatic tumors) from other organs are more common than primary adrenal cancers.

**Why the Correct Answer is Right:**
Among the given options, the correct answer is C. Adrenocortical carcinoma (ACC) is the primary malignant adrenal tumor. ACC is a rare and aggressive malignancy that accounts for only 0.2-0.3% of all adult malignancies. However, it is one of the most lethal malignancies due to its aggressive nature and insensitivity to common cancer therapies.

**Why Each Wrong Option is Incorrect:**
A. Primary adrenal cancer (Cushing's syndrome) is a benign condition, not a malignant one. In Cushing's syndrome, cortisol excess occurs due to a pituitary adenoma (adenoma) or ectopic ACTH-secreting tumors.
B. Metastatic tumors from other organs can lead to adrenal masses, but they are less common than primary adrenocortical carcinoma (option C). Although adrenal hemorrhage can cause adrenal masses, it is not considered a malignant cause.
D. Adrenal hemorrhage results in an adrenal mass due to bleeding into the adrenal gland, which is usually caused by trauma, coagulopathy, or other vascular abnormalities. Adrenal hemorrhage is not a malignant cause.

**Clinical Pearl:**
Adrenocortical carcinoma is a high-grade malignancy with a poor prognosis. Patients may present with a range of symptoms and signs depending on the tumor size, location, and hormonal overproduction. The diagnosis is usually made on the basis of hormonal assays, imaging studies, and histopathology. Treatment options include surgery, chemotherapy, and radiation therapy, but outcomes for patients with ACC are generally poor, with a 5-year survival rate of around 10%.